Joel M. Androphy was a founding force at Berg & Androphy, where he served as partner since 1985. Nationally recognized for his pioneering work in qui tam litigation and whistleblower advocacy, Joel devoted his career to uncovering fraud and championing justice. He played a leading role in the American Bar Association’s National False Claims and Qui Tam Trial Institute and was known for his courtroom expertise and unwavering commitment to legal ethics and reform.
Honored throughout his career for excellence in civil litigation, Joel’s legacy lives on in the countless lives he affected and in the principles that continue to guide our firm.
Androphy wrote more than 75 criminal law and qui tam litigation articles throughout his life, and a book, titled Federal False Claims Act and Qui Tam Litigation (Law Journal Press).
DYNCORP INTERNATIONAL, LLC AND DAMCO U.S.A., INC. PAY $25.4M TO END FALSE CLAIMS ACT SUIT ALLEGING FRAUD RELATED TO MILITARY CONTRACT
DynCorp International, LLC, and Damco U.S.A., Inc. have agreed to pay $25.4 million to resolve a False Claims Act suit alleging that the companies submitted false claims for payment to the Department of Defense related to freight forwarding services provided in Afghanistan as part of the LOGCAP IV program. The settlement resolves a lawsuit against the companies filed in 2014 by two former employees of DynCorp on behalf of the federal government.
$20 MILLION FOR WHISTLEBLOWERS AND THE STATE OF TEXAS
Joel M. Androphy, along with the State of Texas and other law firms, have reached settlements in Texas Medicaid Fraud Prevention Act litigation against AstraZeneca, which charged that AstraZeneca illegally marketed Crestor and profited from its alleged deception through fraudulently garnered reimbursement from Medicaid.
$4.5 MILLION FOR WHISTLEBLOWER AND GOVERNMENT
Joel M. Androphy and Janis Gorton, along with the United States and the State of Texas, have reached a $5 million settlement in a False Claims Act case against Health Services Management, Inc. (HSM) and Huntsville Health Care Center (HHCC) involving billing for poor quality of care and worthless services provided to nursing home patients.
$21 MILLION FOR WHISTLEBLOWERS AND GOVERNMENT
Joel Androphy and David Berg won a settlement to end a False Claims Act case brought by whistleblowers alleging fraudulent Medicaid claims and kickbacks to pharmacies that prescribed an antidepressant drug.
$50 MILLION FOR WHISTLEBLOWERS AND GOVERNMENT
HOUSTON, Sept. 6, 2017 /PRNewswire/ — Joel M. Androphy, along with the U.S. Department of Justice (DOJ) and 50 state Medicaid programs, plus the District of Columbia and the City of Chicago, have reached settlements in False Claims Act (FCA) litigation against Novo Nordisk and their subsidiaries.
WHISTLEBLOWER’S COMPLAINT LEADS BERING STRAITS TECHNICAL SERVICES, L.L.C., AND BERING STRAITS NATIVE CORPORATION TO PAY $2 MILLION TO SETTLE CIVIL FRAUD CHARGES
Whistleblower’s Complaint Leads Bering Straits Technical Services, L.L.C. and Bering Straits Native Corporation to Pay $2 Million to Settle Civil Fraud Charges
Bering Straits Technical Services, L.L.C., and Bering Straits Native Corporation have agreed to pay $2 million to settle civil charges involving alleged violations of the False Claims Act. The settlement was finalized on April 26, 2016, without an admission of liability…
$240 MILLION QUI TAM SETTLEMENT
Joel Androphy, with Esdaile, Barrett, Jacobs & Mone, represented Ryan Uehling, one of the whistleblowers, in a government settlement with Millennium Laboratories, a case involving multiple qui tam actions in the United States District Court in Massachusetts.
$31 MILLION FOR WHISTLEBLOWERS AND GOVERNMENT
Joel Androphy and David Berg, with Esdaile, Barrett, Jacobs & Mone, secured a settlement with drug manufacturer Organon USA Inc. in two qui tam actions in the United States District Courts in Massachusetts and Texas. Organon agreed to settle allegations that it underpaid rebates to state Medicaid programs for several of its drugs, including Remeron, Remeron SolTab, NuvaRing, Mircette, Cyclessa, and Desogen. Additionally, it offered improper financial incentives to nursing home pharmacy companies to induce the prescription of its drugs, Remeron and Remeron SolTab. The settlement netted the clients and government approximately $31 million.
$21 MILLION FOR WHISTLEBLOWERS AND GOVERNMENT IN SETTLEMENT OF GOVERNMENT DECLINED KICKBACK, MEDICAID FRAUD SUIT AGAINST ONMICARE
Joel Androphy and David Berg won a settlement to end a False Claims Act case brought by whistleblowers alleging fraudulent Medicaid claims and kickbacks to pharmacies that prescribed an antidepressant drug.
PHARMERICA PAYS $4.9M TO END FALSE CLAIMS ACT SUIT ALLEGING KICKBACKS AND MEDICAID FRAUD
PharMerica Corporation has agreed to pay $4.9 million to resolve a False Claims Act suit alleging that it took kickbacks from a drug maker to promote two antidepressants.
$1.9 MILLION SETTLEMENT IN WHISTLEBLOWER MILITARY FRAUD CASE
Joel Androphy won a settlement with Frazier Masonry Corporation of Camarillo, California, and other entities and individuals, who agreed to pay nearly $1.9 million to settle civil allegations that they conspired to defraud the United States in connection with military construction projects at Camp Lejeune in North Carolina and Camp Pendleton in California.
$2.3 MILLION SETTLEMENT IN WHISTLEBLOWER MEDICAID FRAUD CASE
Joel Androphy won a settlement with Children’s Physician Services of South Texas, Driscoll Genetic Services, Center for Genetic Services, and Radiology Associates, who agreed to pay $2.3 million to settle civil allegations that they engaged in false or fraudulent conduct by double-billing the Texas Medicaid program, TRICARE, and the Federal Employee Health Benefit Program for the professional reading and interpretation of genetic ultrasounds.
$880,000 FOR WHISTLEBLOWERS AND GOVERNMENT
Joel Androphy won a settlement with Baylor University Medical Center, Baylor Health Care System, and HealthTexas Provider Network (collectively Baylor) in a qui tam action in the United States District Court. Baylor agreed to settle civil charges that it engaged in false or fraudulent conduct by improperly billing federal healthcare programs for robotic stereotactic treatment delivery without corroboration of direct physician supervision and overbilling for services associated with stereotactic procedures without the necessary documentation in the medical record or as duplicative claims for services already performed and paid in conjunction with other services. The settlement netted the clients and government approximately $880,000.
JOEL ANDROPHY WON A SETTLEMENT WITH AMERICAN GROCERS IN A QUI TAM ACTION IN UNITED STATES DISTRICT COURT
The case involved the alteration of expiration dates on food products sent to American troops in the Middle East. The settlement netted the client and the government about $13.2 million.
JOEL ANDROPHY JOINS A TEAM OF LAW FIRMS IN A QUI TAM ACTION THAT NETTED THE GOVERNMENT AND WHISTLEBLOWERS APPROXIMATELY $750 MILLION.
Representing one of nine whistleblowers in a qui tam action, Joel Androphy helped obtain a settlement with Eli Lilly involving fraudulent off-label marketing of the drug Zyprexa. This civil settlement netted the government and all whistleblowers approximately $750 million.
JOEL ANDROPHY WINS SETTLEMENT INVOLVING BEST PRICE VIOLATIONS NETTING THE GOVERNMENT AND WHISTLEBLOWERS $119 MILLION
Joel Androphy won a settlement with King Pharmaceuticals in a qui tam action in United States District Court. The case involved the underpayment of Medicaid rebates, false claims, and best price violations. This settlement netted the client and government about $119 million.
JOEL ANDROPHY WON A SETTLEMENT WITH PFIZER IN A QUI TAM ACTION IN U.S. DISTRICT COURT, NETTING THE CLIENT AND THE GOVERNMENT ABOUT $46 MILLION.
Joel Androphy won a settlement with Pfizer in a qui tam action in U.S. District Court. The case involved the underpayment of medicaid rebates, false claims, and best price violations for the drug Lipitor. The settlement netted the client and government about $46 million. For more information, see the Wall Street Journal, Washington Post, National Law Journal, and other major news archives for October 29, 2002.
JOEL ANDROPHY WINS QUI TAM ACTION INVOLVING DURABLE MEDICAL EQUIPMENT NETTING 1.78 MILLION TO CLIENT AND GOVERNMENT.
Joel Androphy won a settlement with Rotech Healthcare, Inc. in a qui tam action in United States District Court. Rotech paid $2 million to settle civil charges that it engaged in false or fraudulent conduct in billing Medicare for durable medical equipment. The government declined intervention. This settlement netted the client and government about $1.78 million. The negotiated settlement amount reflected Rotech’s stock price of $0.34 per share at the time of settlement, down from $21 in early 2004 when Ms. Bell-Messier filed suit.
JOEL ANDROPHY WITH NORTON A. COLVIN, JR. OF COLVIN, CHANEY, SAENZ & RODRIGUEZ, LLP REPRESENTED ARMANDO VILLALOBOS, THE FORMER DISTRICT ATTORNEY OF CAMERON COUNTY, IN A PUBLIC CORRUPTION TRIAL IN FEDERAL COURT IN BROWNSVILLE, TEXAS.
The government charged Villalobos with twelve counts of racketeering, conspiracy to commit racketeering, extortion, and honest services fraud.
JOEL ANDROPHY WON AN ACQUITTAL OF A U.S. EXECUTIVE ACCUSED OF FOREIGN CORRUPT PRACTICES ACT (FCPA) VIOLATIONS
Joel Androphy secured an acquittal for a U.S. executive accused of violating the Foreign Corrupt Practices Act (FCPA), including payments made to officials of a Mexican state-owned electric utility, on January 18, 2012, following a jury trial in Houston federal court.
JOEL ANDROPHY OBTAINED 4 ACQUITTALS OF A PROMINENT CANCER DOCTOR ACCUSED OF INSURANCE FRAUD BY FOUR MAJOR INSURANCE COMPANIES.
The trial involved billing for the drug Herceptin.
JOEL ANDROPHY OBTAINED A DISMISSAL OF ALL ENVIRONMENTAL CRIMINAL CHARGES AGAINST A SPANISH MARITIME COMPANY.
Joel Androphy obtained a dismissal of all environmental criminal charges against a Spanish maritime company. The international maritime company rejected all attempts by the federal government to obtain corporate pleas.
JOEL M. ANDROPHY OBTAINED AN ACQUITTAL OF A GREEK MARITIME OFFICER
Joel M. Androphy obtained an acquittal for a Greek maritime officer accused of environmental charges by the Department of Justice in a “magic pipe” pollution trial. There have been only two other reported acquittals in the history of these prosecutions.
Additional Criminal Cases